These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7190480)

  • 1. Differential dopaminergic function in young and old female rats as measured by three behaviors.
    Kilbey MM; Ellinwood EH; Gonzalez LP; Cooper RL
    Commun Psychopharmacol; 1980; 4(1):1-9. PubMed ID: 7190480
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral effects of dopamine agonists increase with age.
    Smith RC; Leelavathi DE; Lauritzen AM
    Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 5. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P; Miller RJ; Sahakian B
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
    Hoffmann LC; Schütte SR; Koch M; Schwabe K
    Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Adv Biochem Psychopharmacol; 1980; 24():341-9. PubMed ID: 6105784
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of apomorphine to induce dopaminergic hypersensitivity: a replication.
    Flemenbaum A
    Prog Clin Biol Res; 1981; 68():143-9. PubMed ID: 7197786
    [No Abstract]   [Full Text] [Related]  

  • 10. Actions of dopaminergic agonists on motor function.
    Costall B; Naylor RJ
    Adv Neurol; 1975; 9():285-97. PubMed ID: 1170715
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny.
    Saint Marie RL; Neary AC; Shoemaker JM; Swerdlow NR
    Brain Res; 2006 Nov; 1119(1):203-14. PubMed ID: 16979142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine strongly reduces prepulse inhibition in apomorphine-susceptible rats, but not in apomorphine-unsusceptible rats: regulation by dopamine D2 receptors.
    van der Elst MC; Ellenbroek BA; Cools AR
    Behav Brain Res; 2006 Dec; 175(2):392-8. PubMed ID: 17079027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.
    Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Rak D; Perovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T; Boban-Blagaic A; Bedekovic V; Tonkic A; Babic S
    Acta Pharmacol Sin; 2002 May; 23(5):412-22. PubMed ID: 11978191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HZE radiation and dopaminergic modification of startle and prepulse inhibition in mice.
    Haerich P; Nelson GA; Pecaut MJ
    Physiol Behav; 2005 Sep; 86(1-2):103-10. PubMed ID: 16084538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats.
    de Jong IE; van den Buuse M
    Neuropharmacology; 2006 Sep; 51(3):438-46. PubMed ID: 16740279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats.
    Youdim MB; Yehuda S; Ben-Uriah Y
    Eur J Pharmacol; 1981 Sep; 74(4):295-301. PubMed ID: 7197630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of postsynaptic dopaminergic sensitivity by female sex hormones.
    Nausieda PA; Koller WC; Weiner WJ; Klawans HL
    Life Sci; 1979 Aug; 25(6):521-6. PubMed ID: 573836
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.